Jinhe Biotechnology CO., LTD. (SHE:002688)
China
· Delayed Price · Currency is CNY 6.12
+0.03 (0.49%)
At close: Mar 10, 2026
SHE:002688 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 2,745 | 2,366 | 2,168 | 2,117 | 2,072 | 1,808 | Upgrade
|
| Other Revenue | 4.99 | 4.99 | 6.04 | 5.82 | 5.8 | 6.56 | Upgrade
|
| Revenue | 2,750 | 2,371 | 2,174 | 2,123 | 2,078 | 1,815 | Upgrade
|
| Revenue Growth (YoY) | 21.58% | 9.04% | 2.42% | 2.15% | 14.51% | 1.81% | Upgrade
|
| Cost of Revenue | 1,882 | 1,641 | 1,572 | 1,545 | 1,472 | 1,216 | Upgrade
|
| Gross Profit | 867.44 | 729.97 | 602.51 | 577.47 | 605.66 | 598.34 | Upgrade
|
| Selling, General & Admin | 480.24 | 401.98 | 367.95 | 352.78 | 316.37 | 308.49 | Upgrade
|
| Research & Development | 122.95 | 94 | 74 | 82.28 | 72.25 | 66.36 | Upgrade
|
| Other Operating Expenses | 10.83 | 8.14 | 5.82 | 7.75 | 12.15 | 12.27 | Upgrade
|
| Operating Expenses | 625.92 | 518.11 | 454.08 | 444.34 | 402.65 | 387.4 | Upgrade
|
| Operating Income | 241.51 | 211.85 | 148.43 | 133.13 | 203.01 | 210.94 | Upgrade
|
| Interest Expense | -88.86 | -80.34 | -60.03 | -36.41 | -52.34 | -60.35 | Upgrade
|
| Interest & Investment Income | 5.16 | 6.9 | 8.37 | 1.9 | 1.72 | 9.48 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.92 | 8.92 | 8.85 | 40.34 | -8.83 | -31.58 | Upgrade
|
| Other Non Operating Income (Expenses) | -27.27 | -28.48 | -7.33 | -15.79 | -4.87 | -2.74 | Upgrade
|
| EBT Excluding Unusual Items | 139.47 | 118.85 | 98.29 | 123.18 | 138.68 | 125.77 | Upgrade
|
| Impairment of Goodwill | -39.77 | -39.77 | -5.62 | -7.74 | -11.04 | -8.31 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.6 | -1.22 | -1.52 | -3.94 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.26 | 0.19 | -0.36 | -0.25 | 4.87 | - | Upgrade
|
| Asset Writedown | 15.13 | -1.11 | -0.93 | -0.46 | -1.28 | -2.56 | Upgrade
|
| Other Unusual Items | 20.83 | 20.83 | 11.65 | 8.05 | 11.69 | 26 | Upgrade
|
| Pretax Income | 134.32 | 97.78 | 101.5 | 118.84 | 142.91 | 140.91 | Upgrade
|
| Income Tax Expense | 28.29 | 13.46 | 7.06 | 0.73 | 20.82 | 1.71 | Upgrade
|
| Earnings From Continuing Operations | 106.04 | 84.32 | 94.43 | 118.11 | 122.09 | 139.19 | Upgrade
|
| Minority Interest in Earnings | 19.47 | 15.88 | -7.98 | -42.5 | -28.1 | -21.87 | Upgrade
|
| Net Income | 125.51 | 100.2 | 86.46 | 75.62 | 93.99 | 117.32 | Upgrade
|
| Net Income to Common | 125.51 | 100.2 | 86.46 | 75.62 | 93.99 | 117.32 | Upgrade
|
| Net Income Growth | 29.18% | 15.90% | 14.34% | -19.55% | -19.89% | -36.56% | Upgrade
|
| Shares Outstanding (Basic) | 769 | 774 | 780 | 780 | 696 | 652 | Upgrade
|
| Shares Outstanding (Diluted) | 769 | 774 | 780 | 780 | 696 | 652 | Upgrade
|
| Shares Change (YoY) | -1.32% | -0.76% | -0.01% | 12.16% | 6.74% | 2.21% | Upgrade
|
| EPS (Basic) | 0.16 | 0.13 | 0.11 | 0.10 | 0.14 | 0.18 | Upgrade
|
| EPS (Diluted) | 0.16 | 0.13 | 0.11 | 0.10 | 0.14 | 0.18 | Upgrade
|
| EPS Growth | 30.91% | 16.79% | 14.34% | -28.27% | -24.94% | -37.93% | Upgrade
|
| Free Cash Flow | 144.54 | 136.18 | -258.45 | -277.69 | -230.74 | 54.07 | Upgrade
|
| Free Cash Flow Per Share | 0.19 | 0.18 | -0.33 | -0.36 | -0.33 | 0.08 | Upgrade
|
| Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.100 | - | 0.100 | Upgrade
|
| Dividend Growth | - | - | - | - | - | -60.00% | Upgrade
|
| Gross Margin | 31.55% | 30.79% | 27.71% | 27.20% | 29.15% | 32.97% | Upgrade
|
| Operating Margin | 8.78% | 8.94% | 6.83% | 6.27% | 9.77% | 11.63% | Upgrade
|
| Profit Margin | 4.57% | 4.23% | 3.98% | 3.56% | 4.52% | 6.46% | Upgrade
|
| Free Cash Flow Margin | 5.26% | 5.75% | -11.89% | -13.08% | -11.10% | 2.98% | Upgrade
|
| EBITDA | 435.95 | 397.04 | 321.3 | 282.31 | 333.98 | 330.9 | Upgrade
|
| EBITDA Margin | 15.86% | 16.75% | 14.78% | 13.30% | 16.07% | 18.23% | Upgrade
|
| D&A For EBITDA | 194.43 | 185.19 | 172.86 | 149.18 | 130.97 | 119.95 | Upgrade
|
| EBIT | 241.51 | 211.85 | 148.43 | 133.13 | 203.01 | 210.94 | Upgrade
|
| EBIT Margin | 8.78% | 8.94% | 6.83% | 6.27% | 9.77% | 11.62% | Upgrade
|
| Effective Tax Rate | 21.06% | 13.77% | 6.96% | 0.61% | 14.57% | 1.21% | Upgrade
|
| Revenue as Reported | 2,750 | 2,371 | 2,174 | 2,123 | 2,078 | 1,815 | Upgrade
|
| Advertising Expenses | - | 27.74 | 20.64 | 12.16 | 5.36 | 2.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.